Expression of an activated form of calcineurin in skeletal muscle selectively up-regulates slowfiber-specific gene expression. Here, we tested the hypothesis that expression of activated calcineurin in skeletal muscle influences body composition, energy homeostasis, and exercise performance. Using transgenic mice expressing activated calcineurin (CnA*) in skeletal muscle (MCK-CnA* transgenic mice), we determined whether skeletal muscle reprogramming by calcineurin activation affects exercise performance and skeletal muscle mitochondrial function. Body weight and extensor digitorum longus (EDL) skeletal muscle weight were reduced 10% in MCK-CnA* mice compared with wild-type littermates. Basal oxygen consumption, food intake, and voluntary exercise behavior were unchanged between MCK-CnA* and wild-type mice. However, when total energy expenditure was normalized by fat-free mass, energy expenditure was increased in MCK-CnA* mice. An endurance performance treadmill running test revealed MCK-CnA* mice are fatigue resistant and run 50% farther before exhaustion. After a standardized exercise bout, glycogen and triglyceride content in EDL muscle was higher in MCK-CnA* vs. wild-type mice. Mitochondrial respiratory capacity was increased 35% in EDL muscle from resting MCK-CnA* mice. In conclusion, our results provide evidence to support the hypothesis that calcineurin activation in skeletal muscle increases mitochondrial oxidative function and energy substrate storage, which contributes to enhanced endurance exercise performance. These adaptive changes occur as a consequence of a lifelong expression of a constitutively active calcineurin and mimic the response to chronic endurance training.
energy homeostasis; exercise; calcium; contractile activity; bioenergetics SKELETAL MUSCLE REPRESENTS ϳ55% of individual body mass in most mammals (45) , and it is, therefore, a major contributor to whole body energy expenditure during physical activity. Energy substrate utilization in skeletal muscle is balanced between glucose and lipid metabolism, depending upon the physiological demand. In lean, healthy people, skeletal muscle mainly relies on lipid oxidation during fasting or sustained aerobic exercise and glucose oxidation in the fed or insulinstimulated state or with high-intensity exercise (18) . In patients with type 2 diabetes, the ability of skeletal muscle to switch between lipid and glucose oxidation in response to fasting or feeding, respectively, is impaired, and this "metabolic inflexibility" may constitute a primary event in the development of insulin resistance and obesity (18, 38) .
Skeletal muscle is composed of distinct cells that are classified into slow-and fast-twitch fibers, based on their contractile properties. Slow-twitch and fast-twitch fiber types also differ in energy metabolism and enzymatic properties. Fasttwitch fibers have a greater glycolytic potential, contain more glycogen, and reach peak tension faster than slow-twitch fibers (45) . Slow-twitch fibers have a greater oxidative potential and increased triglyceride content compared with fast-twitch fibers (45) . Fiber type-specific gene expression programs are activated during development in the embryonic myoblast (7, 30) , thereby establishing intrinsic metabolic characteristics from birth. Frequent neural stimulation of skeletal muscle fibers maintains the intracellular free calcium concentration at a constant high level and activates the slow-twitch, fiber-specific program through the Ca 2ϩ /calmodulin-dependent protein serine/threonine phosphatase calcineurin (6) . Activated calcineurin can reprogram skeletal muscle fibers from a fast-to a slow-twitch phenotype (28) .
Calcineurin is a heterodimeric protein phosphatase composed of a catalytic subunit A (CnA) and a regulatory subunit B (32) . Activation of calcineurin induces the binding of nuclear factor of activated T cells (NFAT) to the promoter region of slow-fiber-specific genes, resulting in the transcriptional activation of a slow-fiber gene expression and contractile program (6) . A deletion mutant of the calcineurin subunit A (CnA*), lacking the carboxyl-terminal autoinhibitory domain that binds calcium/calmodulin, was found to be constitutively active (29) . Transgenic expression of CnA* under the muscle creatine kinase (MCK) promoter increased the percentage of slow oxidative muscle fibers (28) . Expression of MCK-CnA* was restricted to skeletal muscle, and mRNA was undetected in all other tissues, except cardiac muscle (28) . Further analysis revealed insulin-stimulated glucose transport was increased, glycogen synthesis and lipid oxidation were increased, and glucose oxidation was reduced in glycolytic skeletal muscle MCK-CnA* mice (22, 33) . These metabolic changes in MCKCnA* mice occurred in concert with increased mitochondrial markers (22) , providing evidence to suggest that activated calcineurin promoted a shift in muscle substrate utilization from glucose to lipids. Deficiency of calsarcin-2, a suppressor of calcineurin that is exclusively expressed in fast-twitch muscle, was reported to decrease body weight and increase endurance performance (9) .
Here, we tested the hypothesis that expression of activated calcineurin in skeletal muscle influences body composition, energy homeostasis, and exercise performance. Furthermore, we determined whether activated calcineurin increases skeletal muscle mitochondrial function.
MATERIALS AND METHODS
Materials. Saponin, pyruvate, ADP, cytochrome c, L-glutamic acid monosodium salt hydrate, sodium succinate dibasic hexahydrate, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), rotenone, and antimycin A were obtained from Sigma-Aldrich (St. Louis, MO).
Animals. A line of transgenic mice expressing a constitutively active form of calcineurin (29) under the control of the MCK promoter/enhancer (MCK-CnA* mice) and wild-type littermates was established at the Karolinska Institutet using MCK-CnA* mice (28) that were originally from Dr. Eric N. Olson (University of Texas Southwestern Medical Center, Dallas, TX). MCK-CnA* transgenic mice and wild-type littermates were maintained on a 12:12-h lightdark cycle and given free access to food and water. Female mice were weighed and anesthetized via intraperitoneal injection of 2.5% Avertin (0.02 ml ϫ gram body wt). Tissues were harvested for biochemical analysis and immediately thereafter, mice were humanely killed by cervical dislocation. Individual tissues and organs, including skeletal muscle [extensor digitorum longus (EDL) and soleus], liver, heart, kidney, and fat (intraperitoneal, perirenal, mesenteric, and brown) were dissected and weighed. The regional animal ethics committee of Northern Stockholm approved all experimental procedures.
Whole body energy homeostasis. Food intake, oxygen consumption, respiratory exchange ratio (RER), and locomotor activity were measured using a Comprehensive Lab Animal Monitoring System (Columbus Instruments, Columbus, OH). Female mice were housed individually in metabolic cages with ad libitum access to standard chow and water. Mice were acclimatized to the metabolic cages for 48-h prior to a 24-h period of automated recordings every 20 min. Oxygen consumption (V O2) was determined by an open-circuit Oxymax. Sample air from individual cages was passed through sensors to determine O2 and CO2 content. Oxygen consumption was calculated as the difference between the input oxygen flow and the output oxygen flow. The RER was calculated as the ratio between the CO 2 production and the O2 consumption. Ambulatory locomotor activity was measured by consecutive beam breaks in adjacent beams under the 24-h period. Lean body mass was determined by MRI (Echo Medical Systems, LLC, Houston, TX).
Voluntary running exercise. MCK-CnA* and wild-type mice were matched for age and body weight at the onset of the exercise protocol. Whole body composition was measured before and after the exercise protocol. Mice were maintained for 4 wk on a 12:12-h light-dark cycle, with free access to food and water. Each cage was equipped with a running wheel. Voluntary running distance was automatically recorded using a computer.
Endurance running test. Mice were acclimated to the treadmill (Simplex II Instrument; Columbus Instruments, Columbus, OH) during a 3-day running protocol. Mice ran at a speed of 10 m/min with 0% slope for 5 min on day 1 and 10 min on day 2. On days 3 and 4, the initial speed was set at 10 m/min, and gradually increased to 20 m/min (day 3) or 24 m/min (day 4), with a 10% slope. All mice ran 20 min on day 3 of the protocol. On day 4, mice ran until exhaustion at a maximum speed of 24 m/min. Mice were not allowed to run more than 60 min. Exhaustion was defined when mice refused to run in response to a tap on the lower back.
Standardized exercise bout. Mice were acclimated to the treadmill using the 3-day running protocol described above. On day 4, mice were subjected to a standardized exercise bout that was based on the average running time achieved by the wild-type mice during the endurance running test. Thus, MCK-CnA* and wild-type mice ran at a maximum speed of 24 m/min for 30 min. Mice were anesthetized, as described above immediately after the exercise bout, and EDL muscle, soleus muscle, and liver were dissected and directly frozen in liquid nitrogen for subsequent biochemical analysis. During the same experiment, nonexercise control mice were also anesthetized, and tissues were dissected and frozen as described above for the biochemical analysis.
Triglyceride measurements. Whole EDL and soleus muscle and a portion of the liver (4 -8 mg) were homogenized in individual tubes containing 600 l of a heptan-isopropanol 3:2 mixture, with 1% Tween-20 using TissueLyser II (cat. no. 85300; QIAGEN, Valencia, CA). Lipids extracted from 100 l of the supernatant were dried and analyzed for total triglyceride content using a triglyceride/glycerol kit (cat. no. 12146029; Roche Diagnostics, Mannheim, Germany), with Precinorm L (cat. no. 10781827122; Roche) as a standard.
Glycogen measurement. Glycogen content in skeletal muscle and liver was measured fluorometrically as previously described (40) .
Mitochondrial respiration. Mitochondrial respiration was determined as previously described (11) . EDL muscles were dissected and incubated in cold buffer (BIOPS solution, 2.77 mM CaK2EGTA, 7.23 mM K 2EGTA, 5.77 mM Na2ATP, 6.56 mM MgCl2, 20 mM touraine, 15 mM Na2 phosphocreatine, 20 mM imidazole, 0.5 mM dithiotreitol, 50 mM MES, pH 7.1). Muscle fibers were separated under a microscope and transferred to a permeabilization solution (0.05 mg/ml saponin in BIOPS). Muscle fibers were incubated on ice with agitation for 30 min, then transferred to cold medium (MiR05 solution, 0.5 mM EGTA, 3 mM MgCl2, 60 mM K-lactobionate, 20 mM taurine, 10 mM KH2PO4, 20 mM HEPES, 110 mM sucrose, 1 g/l BSA, pH 7.1), and incubated on ice for 10 min. Muscle fibers (1-2 mg) were placed in a chamber containing 2 ml MiR05 solution within a high-resolution respirometry system (Oxygraph-2k; Oroboros Instruments, Innsbruck, Austria), and the rate of oxygen consumption was determined.
Western blot analysis. Muscles were pulverized in microcentrifuge tubes over liquid nitrogen and homogenized by motor pestle in 0.3 ml of ice-cold lysis buffer containing 20 mM Tris (pH 8.0), 137 mM NaCl, 2.7 mM KCl, 10 mM NaF, 1 mM MgCl, 1 mM Na 3VO4, 0.2 mM phenylmethylsulfonyl fluoride, 10% glycerol, 1% Triton ϫ 100, 1 g/ml aprotinin and 1 g/ml leupeptin (22) . Homogenates were solubilized by end-over-end mixing at 4°C for 60 min and subjected to centrifugation for 10 min at 12,000 g and 4°C. Total protein was determined using a commercially available kit (Pierce, Rockford, IL), and proteins (50 g) solubilized in Laemmli sample buffer were separated by SDS-PAGE and transferred to Immobilon-P membranes (Millipore, Bedford, MA). Western blot analysis was performed using the following antibodies: PGC1 (Chemicon, Temecula, CA), cluster of differentiation 36 (CD36), acyl-CoA:monoacylglycerol acyltransferase-1 (MGAT1) (Santa Cruz Biotechnology, Santa Cruz, CA), and fatty acid transport protein-1 (FATP1; kind gift from Daiichi-Sankyo, Tokyo, Japan). Proteins were visualized by chemiluminescence and quantified by densitometry.
Quantitative real-time PCR. The quantity of cDNA for each transcript was measured using real-time PCR with the ABI PRISM 7000 Sequence Detector System and fluorescence-based SYBR-Green technology (Applied Biosystems, Warrington, UK) (22) . PCR was performed in a final volume of 25 l consisting of diluted cDNA sample, 1ϫ SYBR-Green PCR Master Mix (Applied Biosystems), primers optimized for each target gene, and nuclease-free water. All samples were analyzed in duplicate. Relative quantities of target transcripts were calculated from duplicate samples after normalization of the data against housekeeping gene (18S ribosomal RNA) using the standard curve method. Primers were designed based on transcript sequences obtained from ENSEMBL database using Jemboss software (The European Molecular Biology Open Software Suite). Sequence for the primers: DGAT1-forward, GCTTCTGCAGTTTGGAGACC; DGAT1-reverse, CTCATGGAAGAAGGCTGAGG; DGAT2-forward, TCTCAGCCC-TCCAAGACATC; DGAT2-reverse, GCCAGCCAGGTGAAGTAGAG; 18S-forward, AGTCCCTGCCCTTTGTACACA; 18S-reverse, GATCC-GAGGGCCTCACTAAAC.
Statistical analysis. Data are reported as means Ϯ SE. Differences between the two groups were determined by Student's t-test. Significance was accepted at P Ͻ 0.05.
RESULTS
Anthropometric analysis. Body weight was reduced 10% in MCK-CnA* mice (Table 1) . EDL skeletal muscle weight was also reduced 10% in MCK-CnA* mice, whereas the weight of soleus muscle, various fat pads (intraperitoneal, perirenal, mesenteric, and brown fat), liver, and kidney was unchanged (Table 1) . Consistent with previous data (39), heart weight was increased 25% in MCK-CnA* mice (Table 1) .
Whole body energy expenditure. Total energy expenditure and RER were unaltered between MCK-CnA* and wild-type mice. However, when total energy expenditure was normalized by fat-free mass, energy expenditure in the dark and light cycle was increased in MCK-CnA* mice compared with wild-type littermates (Fig. 1A) . Food intake, oxygen consumption, and spontaneous locomotor activity was unaltered between MCKCnA* and wild-type mice (Fig. 1, B-D) . Food intake per gram fat free mass was unchanged in MCK-CnA* mice.
Response to voluntary exercise. Expression of MCK-CnA* induces fast-to-slow skeletal muscle fiber-type reprogramming (28) . Skeletal muscle fiber type composition has the potential to influence exercise performance (45) . Therefore, we assessed whether voluntary exercise is altered in MCK-CnA* mice. MCK-CnA* and wild-type mice performed similar amounts of voluntary wheel-running exercise during the dark cycle, and they remained sedentary during the light cycle ( Fig. 2A) . Body weight was unaltered after the 4-wk voluntary exercise protocol in either MCK-CnA* or wild-type mice. However, fat mass was reduced and lean mass was increased in MCK-CnA* and wild-type mice, with similar responses between the two genotypes (Fig. 2B) . Our results provide evidence to suggest that the response to voluntary exercise is unaltered in MCK-CnA* mice.
Endurance exercise performance. We next investigated whether the endurance capacity and response to intensive exercise is altered in MCK-CnA* mice. Mice ran on a motordriven treadmill at a final speed of 24 m/min until exhaustion, or for a maximum duration of 1 h. Four of the eighteen MCK-CnA* mice and one of the fifteen wild-type mice were removed from the treadmill after 1 h of exercise. Running distance was increased 33% in MCK-CnA* mice compared with wild-type mice (Fig. 3) . Our results provide evidence to suggest that skeletal muscle-specific expression of CnA* is sufficient to increase endurance exercise performance.
Glycogen and triglyceride content after standardized exercise. MCK-CnA* mice and wild-type littermates were randomly allocated to either a sedentary or treadmill exercise group. Mice in the treadmill exercise group performed a standardized exercise bout on motor-driven treadmill. MCKCnA* and wild-type mice ran a similar distance (551 Ϯ 47 vs. 584 Ϯ 56 m, respectively). Skeletal muscle (EDL and soleus) and liver were dissected immediately after exercise for biochemical analysis of glycogen (Fig. 4A) exercise bout, glycogen (Fig. 4A) and triglyceride (Fig. 4B ) content in EDL muscle remained higher in MCK-CnA* vs. wild-type mice. In oxidative soleus muscle, glycogen content was similar (Fig. 4A) , and triglyceride content was lower ( Skeletal muscle mitochondrial oxidative capacity. Expression of several mitochondrial marker genes are increased in skeletal muscle from MCK-CnA* mice (22) . Therefore, we determined whether mitochondrial oxidative capacity is altered in skeletal muscle from MCK-CnA* mice. Electron transfer and respiratory control through complex I (by adding malate, glutamate, and pyruvate) and/or complex II (by supplying succinate) were measured in permeabilized EDL skeletal muscle fibers. Excess ADP was added to assess electron transfer coupled to oxidative phosphorylation. The mitochondrial uncoupler FCCP was added to maximally stimulate the electron transfer system. Electron transport through complex I and III was inhibited by sequential addition of rotenone (CIi) and antimycin A, respectively. The remaining O 2 flux after inhibition of complex I and III by rotenone and antimycin A (O 2 flux independent of the electron transfer system) was subtracted from each of the previous steps. Oxygen flux was reported as respiration per muscle mass (J O2 ) (Fig. 5A ), or as substrate control ratios taking the maximum oxygen flux for each sample as a reference (Fig. 5B) . Basal respiratory oxidation through complex I was unchanged (leak), but the maximum oxidative capacity through both complex I and II was increased in skeletal muscle from MCK-CnA* mice (Fig. 5A) . The magnitude of this increase was similar for complex I and II (Fig. 5B) . Our results provide evidence that increased mitochondrial function could provide a potential mechanism for the increased endurance performance in MCK-CnA* mice.
PGC1-␣ expression. PGC1-␣ is regarded as a master regulator of mitochondria biogenesis (21) . Protein expression of PGC1-␣ was increased 33% in EDL (Fig. 6A ), but unchanged in soleus (Fig. 6B ) muscle from MCK-CnA* vs. wild-type mice.
Fatty acid transporter expression. To further address the genotype effect of activated calcineurin on EDL and soleus triglyceride levels, genes and proteins of relevance for lipid accumulation or triglyceride synthesis were assessed. Free fatty acid import and triglyceride synthesis is partly dependent upon fatty acid translocase (CD36) and FATP1 [reviewed by Bonen et al. (4) ]. Protein expression of CD36 was increased 33%, and FATP1 was decreased 37% in EDL muscle from MCK-CnA* mice compared with wild-type mice (Fig. 7, A  and C) . However, in soleus muscle, CD36 and FATP1 expression was unaltered in MCK-CnA* vs. wild-type mice (Fig. 7, B and D) .
Triglyceride synthesis enzyme expression. Monoacyglycerol acyltransferases (MGATs) and diacylglycerol acyltransferases (DGATs) control the last two steps in triglyceride synthesis [reviewed by Shi and Cheng (36)]. MGAT and DGAT catalyze the conversion from monoacylglycerol to diacylglycerol, and from diacylglycerol to triglyceride, respectively. MGAT1 protein expression in EDL and soleus muscle was unaltered between MCK-CnA* and wild-type mice (Fig. 8, A and B) . We detected DGAT1 and DGAT2 mRNA in EDL and soleus muscle (Fig. 8C) , with DGAT2 identified as the major isoform. DGAT2 mRNA was increased 6-fold in EDL muscle, but unchanged in soleus muscle from MCK-CnA* vs. wild-type mice (Fig. 8C) . DGAT1 mRNA in either EDL or soleus muscle was unaltered between MCK-CnA* and wild-type mice (Fig. 8C) .
DISCUSSION
Here, we report that skeletal muscle mitochondrial oxidative capacity and endurance exercise performance are increased in MCK-CnA* mice. This finding is consistent with gene expression analysis, indicating that the mitochondrial biogenesis marker gene PGC-1␣ is increased in skeletal muscle from MCK-CnA* mice (22) . The increase in exercise performance in the MCK-CnA* mice is also observed in mice deficient in calcineurin inhibitor protein calsarcin-2 (9), which further implicates calcineurin/NFAT activation. Our study provides direct evidence that activated calcineurin in skeletal muscle enhances endurance performance. A: oxidative phosphorylation and electron transport system capacity (JO2) in permeabilized muscle fibers incubated with substrates for electron supply through Complex I (CIb, malateϩpyruvate). To maximize oxidative phosphorylation from complex I, ADP and glutamate were added in sufficient amounts to couple (c) electron transfer to ATP production (CIc). To assess the combined oxidative phosphorylation activity of complex I and II, succinate was added (CIϩIIc). Maximal capacity of the electron transfer system (ETSIϩII) by complex I and II was obtained by adding the uncoupler FCCP. The contribution of the complex II pathway was obtained by adding the complex I inhibitor rotenone (CIi). B: substrate control ratio is expressed as a percentage of maximum oxygen flux. Values are expressed as means Ϯ SE for n ϭ 7 mice (2-3 muscle preparations were analyzed for each mouse). *P Ͻ 0.05 vs. wild-type mice.
Peroxisome proliferator-activated receptor ␥ (PPAR␥) coactivator 1 ␣ (PGC1␣) induces mitochondrial biogenesis by activating transcription of mitochondrial transcription factor A (Tfam), which is a direct regulator of mitochondrial DNA replication/transcription (44) . Transgenic expression of PGC1␣ in mice increases mitochondrial content, as evidenced by elevated expression of several mitochondrial enzymes, including cytochrome c oxidase (COX) II and IV (21) . Modest overexpression of PGC1␣ specifically in skeletal muscle by electroporation also induces mitochondrial biogenesis in a dose-dependent manner (2) . Although physical exercise training increases PGC1␣ expression (10, 20) and mitochondrial biogenesis (10) via a calcineurin-independent pathway, gene transfer of calcineurin into skeletal muscle by electroporation can activate the PGC1␣ promoter, thereby mimicking the effects of exercise (13) . PGC1␣ protein content is increased 33% in EDL muscle from MCK-CnA* mice (Fig. 6A) . Interestingly, myocyte enhancer factor-2, a transcription factor which is involved in regulation of GLUT4 expression, can be activated by both PGC1␣ (21) and calcineurin (43) . Therefore PGC1␣ and calcineurin may function synergistically to alter gene expression to enhance metabolism, including insulinstimulated glucose uptake and protection against dietary induced insulin resistance (33) . Thus, PGC1␣ is likely to play a profound role in the calcineurin-dependent signaling pathway to promote increased mitochondrial oxidative capacity.
The regulation of mitochondrial biogenesis and oxidative capacity is complex, and multiple pathways are likely to be involved. Transgenic expression of an activated form of PPAR␦ in skeletal muscle promotes mitochondrial biogenesis (41) . Treatment of mice with a PPAR␣ agonist also increases the expression of carnitine palmitoyltransferase I (CPT1) and promotes skeletal muscle palmitate oxidation (25) . PPAR␦, PPAR␣, CPT1, as well as several other enzymes essential for lipid oxidation, including CPT2, LPL, and CD36 are increased in EDL muscle from MCK-CnA* mice (22) . 5Ј AMP-activated protein kinase (AMPK) also exerts a profound effect on mitochondrial biogenesis. Skeletal muscle mitochondrial content is increased after chronic pharmacological AMPK activation (3) or in transgenic mice expressing an activated form of the AMPK␥3 subunit (11) . Conversely, AMPK␣2 knockout mice (17) and transgenic mice expressing a dominant-negative AMPK mutant (46) have reduced mitochondrial markers and impaired energy deprivation-induced mitochondrial biogenesis, respectively. Interestingly expression of the AMPK␥3 subunit, the predominant form in fast glycolytic muscle (24) , is downregulated in MCK-CnA* mice (34) . Collectively, additional regulators including PPAR␦ and PPAR␣, but not AMPK, are likely to increase mitochondrial function in MCKCnA* mice.
Similar to MCK-CnA* mice, several other transgenic mice strains also exhibit enhanced endurance performance or fatigue resistance. PGC-1␤ transgenic mice run ϳ50% longer than wild-type littermates (1) . Furthermore, EDL muscle from PGC-1␣ transgenic vs. wild-type mice is fatigue resistant (21) . Transgenic mice with activated PPAR␦ expressed in skeletal muscle run up to twice the distance of wild-type littermates (41) . Mice with deficiency of calsarcin-2, an endogenous calcineurin inhibitor, run 70% further than wild-type littermates (9) . Endurance performance is also increased in actinin-3-deficient mice (23) . The increased endurance performance or fatigue resistance in these animal models, as well as observed here in MCK-CnA* mice, is generally accompanied by increased mitochondrial content or gene expression (1, 9, 21, 23, 41) . Thus, increased mitochondrial function appears to be a common mechanism associated with enhanced endurance performance.
The molecular mechanisms controlling the plasticity of skeletal muscle to adapt to alterations in oxidative demand through adjusting the mitochondrial oxidative capacity is of physiological relevance. In Type 2 diabetes patients with reduced skeletal muscle mitochondrial content (19) , the residual mitochondrial capacity is estimated to be sufficient for energy production under basal (resting) physiological conditions (14) . Therefore, the total mitochondrial oxidative capacity is in far excess of what is required to sustain metabolism at rest. Thus, perhaps it is unsurprising that basal oxygen consumption and voluntary exercise performance were similar between MCK-CnA* and wild-type mice. However, after adjusting for lean mass, energy expenditure was higher in MCKCnA* mice. The reduced body weight in the MCK-CnA* mice may be beneficial to running economy. However, increased mitochondrial function is also associated with enhanced endurance performance (8) . Thus, the increased endurance exercise capacity in MCK-CnA* mice may be a consequence of enhanced skeletal muscle bioenergetics.
Glycogen and triglyceride are important energy substrates for skeletal muscle. To meet the demands of moderate to intensive exercise (65-85% V O 2 max ) in humans, muscle glycogen mainly contributes 30 -60%, and intramuscular triglyceride contributes 15-20% to total energy expenditure (31) . Endurance exercise training increases the glycogen storage capacity of skeletal muscle (27) . Here, we found glycogen and triglyceride content were higher in EDL muscle from untrained MCK-CnA* mice compared with wild-type littermates, even after an acute exercise bout. These biochemical adaptations in skeletal muscle from MCK-CnA* mice may account for their enhanced endurance exercise performance. While the reduction in liver glycogen content after an acute exercise bout is relatively minor compared with the changes noted in EDL and soleus muscle, liver triglyceride content was unaltered. On the basis of these comparisons between skeletal muscle and liver, and also the relative greater mass of muscle vs. liver in MCK-CnA* mice, we suggest intramuscular glycogen and triglyceride contributes to energy expenditure during exercise in this mouse model. However, we cannot exclude the possibility that adipose tissue contributes to whole body energy utilization. Paradoxically, MCK-CnA* mice have enhanced insulin sensitivity and increased triglyceride levels in EDL muscle (22, 33) . Although intramuscular triglyceride content is inversely correlated with insulin sensitivity (8) , it is unlikely to directly cause insulin resistance, since insulin-sensitive endurance-trained athletes also have elevated intramuscular triglyceride content (12) . This paradox may be explained by the observation that in times of excessive calorie intake, an increase in lipid derivatives, including ceramide (35) and diaglycerol (5, 16), may cause peripheral insulin resistance and beta cell failure (37). Transgenic expression of activated calcineurin in heart induces massive cardiac hypertrophy and heart failure (26) . MCK-CnA* is also expressed in heart, and consequently, we observed mild cardiac hypertrophy in the transgenic mice. Voluntary exercise also induces mild cardiac hypertrophy, which is associated with increased myocardial compliance and health benefits (42) . Whether the cardiac output was also changed in MCK-CnA* is unknown. Thus, any possible contribution of the increased MCK-CnA* expression in heart to the superior endurance performance observed in the transgenic mice cannot be excluded.
Activated calcineurin promotes enhanced insulin sensitivity in skeletal muscle, as evidenced by increased glucose uptake and metabolism concomitant with increased protein expression of GLUT4, hexokinase 2 (HK2), and glycogen synthase in EDL muscle from MCK-CnA* mice (22, 33) . This increased expression of proteins, which is important for glucose uptake, metabolism, and storage may provide a mechanism for the increased glycogen storage noted in sedentary and exercised MCK-CnA* mice. The increased triglyceride storage in EDL muscle from MCK-CnA* mice may be related to alterations in the expression of genes involved in cellular fatty acid transport or triglyceride synthesis, such as fatty acid translocase (CD36) or fatty acid transporter proteins (FATP1) [reviewed by Bonen et al. (4)]. Interestingly, CD36 expression is increased in skeletal muscle in response to electrically stimulated muscle contractions (15) , suggesting that CD36 may be important for meeting the increased metabolic demands during exercise. Indeed, we found increased CD36, but decreased FATP1 expression in EDL muscle from MCK-CnA* mice, providing evidence that increased fatty acid import may account for the increased triglyceride levels. Alternatively, triglyceride synthesis may be enhanced. Monoacyglycerol acyltransferases (MGATs) and diacylglycerol acyltransferases (DGATs) catalyze the last two steps in triglyceride synthesis [reviewed by Shi and Cheng (36) ]. Here, we found that while MGAT1 and DGAT1 expression was unchanged between MCK-CnA* and wild-type mice, DGAT2 expression was markedly increased. Thus, alterations in the expression of the fatty acid transporter protein CD36 and enzymes important for triglyceride synthesis, such as DGAT2, may provide a mechanism for the increased triglyceride storage in EDL muscle from MCK-CnA* mice.
In conclusion, our results provide evidence to support the hypothesis that calcineurin activation in skeletal muscle increases mitochondrial oxidative function and energy substrate storage, which contributes to enhanced endurance exercise performance. These biochemical changes occur as a consequence of a lifelong expression of a constitutively active calcineurin, and they mimic the response to chronic endurance training. Thus, calcineurin, together with other molecular targets, including PPAR␦, PCG1␣, and AMPK, plays a role in enhancing skeletal muscle energetics, further promoting oxidative metabolism. 
